Spragens Jeffrey G Insider Trades

Insider Trading History

Track insider trading activity for Spragens Jeffrey G. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $200 20,000 shares
Last Trade
Jul 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$766 20,000 shares
$0.04
$0.01
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $77.4k 20,000 shares
Last Trade
Jul 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$58k 20,000 shares
$2.90
$3.87
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $77.2k 19,936 shares
Last Trade
Feb 28, 2023 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$130k 19,936 shares
$6.50
$3.87
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $199 19,936 shares
Last Trade
Feb 28, 2023 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.01
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $3.95k 394,989 shares
Last Trade
Dec 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.01
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $1.53M 394,989 shares
Last Trade
Dec 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.63M 165,974 shares
$9.82
$3.87
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $1.21M 312,002 shares
Last Trade
May 20, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$5.74M 299,002 shares
$19.20
$3.87
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $3.12k 312,002 shares
Last Trade
May 20, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.01
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $130 13,000 shares
Last Trade
Oct 01, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.01
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $50.3k 13,000 shares
Last Trade
Oct 01, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$131k 13,000 shares
$10.07
$3.87
SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt)
SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) BCYPU
Director
Holding Value $111k 13,000 shares
Last Trade
Oct 01, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$131k 13,000 shares
$10.07
$8.57
Big Cypress Acquisition
Big Cypress Acquisition BCYP
Director
Holding Value $110k 13,000 shares
Last Trade
Oct 01, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$131k 13,000 shares
$10.07
$8.44
Big Cypress Acquisition - Warrants (25/07/2027)
Big Cypress Acquisition - Warrants (25/07/2027) BCYPW
Director
Holding Value $14.3k 13,000 shares
Last Trade
Oct 01, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.8k 13,000 shares
$0.98
$1.10
Asensus Surgical
Asensus Surgical ASXC
10% owner, President And CEO
Holding Value $52.2k 150,000 shares
Last Trade
Apr 23, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.35
Asensus Surgical
Asensus Surgical ASXC
10% owner, President And CEO
Holding Value $886k 2,545,285 shares
Last Trade
Mar 22, 2013 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.35
Asensus Surgical
Asensus Surgical ASXC
10% owner, President And CEO
Holding Value $0 0 shares
Last Trade
Mar 22, 2013 Sale (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.35
Asensus Surgical
Asensus Surgical ASXC
10% owner, President And CEO
Holding Value $746k 2,145,285 shares
Last Trade
Oct 25, 2012 Purchase (In The Money)Reported as In The Money on SEC Form 4.
No data
No data
$0.35
Asensus Surgical
Asensus Surgical ASXC
10% owner, President And CEO
Holding Value $0 0 shares
Last Trade
Oct 25, 2012 Sale (In The Money)Reported as In The Money on SEC Form 4.
No data
No data
$0.35
Asensus Surgical
Asensus Surgical ASXC
10% owner, President And CEO
Holding Value $739k 2,125,147 shares
Last Trade
Feb 17, 2012 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.35
Asensus Surgical
Asensus Surgical ASXC
10% owner, President And CEO
Holding Value $34.8k 100,000 shares
Last Trade
Feb 16, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.35

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up